Article History
Accepted: 13 November 2020
First Online: 24 November 2020
Declarations
:
: This study includes research content that AY has conducted during his doctoral studies at the International University of Health and Welfare. AY and NY were responsible for the study conceptualization. AY and ML were responsible for overseeing the data extraction and reporting of the results. All of the authors contributed to the review, revision, and finalization of the final manuscript.
: All data generated or analyzed during this study are included in this published article (and its supplementary information files).
: The authors declare the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Akira Yuasa and Naohiro Yonemoto are full-time employees of Pfizer Japan Inc. Michael LoPresti is a full-time employee of INTAGE Healthcare Inc. Shunya Ikeda declares no conficts of interest associated with this manuscript.
: Pfizer Japan Inc. was the only direct sponsor of this study, and fees were paid to INTAGE Healthcare Inc. Akira Yuasa and Naohiro Yonemoto are employees of Pfizer Japan Inc. and were involved in substantial contributions to the conception, design, analysis of data and the subsequent drafting of this work.